Purchases and Sales Made in Q4 2022 in Oramed Pharmaceuticals Inc. (ORMP)
This table provides information about the institutional ownership of Oramed Pharmaceuticals Inc. (ORMP) during Q4 2022. The information is specifically focused on institutions that hold shares of ORAMED PHARMACEUTICALS INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-50.7K- 47.47% |
$298K - $610K
|
56.1K
$133K
|
|
|
Feb 14, 2023
Q4 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-79.6K- 24.01% |
$468K - $958K
|
252K
$597K
|
|
|
Feb 14, 2023
Q4 2022
|
Cubist Systematic Strategies, LLC
Stamford, CT |
SELL
|
- |
-93K- 79.14% |
$547K - $1.12M
|
24.5K
$58.1K
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-211K- 39.98% |
$1.24M - $2.53M
|
316K
$750K
|